Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,856 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Loras C, Saro C, Gonzalez-Huix F, Mínguez M, Merino O, Gisbert JP, Barrio J, Bernal A, Gutiérrez A, Piqueras M, Calvet X, Andreu M, Abad A, Ginard D, Bujanda L, Panés J, Torres M, Fernández-Bañares F, Viver JM, Esteve M; GETECCu (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa). Loras C, et al. Among authors: torres m. Am J Gastroenterol. 2009 Jan;104(1):57-63. doi: 10.1038/ajg.2008.4. Am J Gastroenterol. 2009. PMID: 19098850
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.
Loras C, Gisbert JP, Mínguez M, Merino O, Bujanda L, Saro C, Domenech E, Barrio J, Andreu M, Ordás I, Vida L, Bastida G, González-Huix F, Piqueras M, Ginard D, Calvet X, Gutiérrez A, Abad A, Torres M, Panés J, Chaparro M, Pascual I, Rodriguez-Carballeira M, Fernández-Bañares F, Viver JM, Esteve M; REPENTINA study; GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) Group. Loras C, et al. Among authors: torres m. Gut. 2010 Oct;59(10):1340-6. doi: 10.1136/gut.2010.208413. Epub 2010 Jun 24. Gut. 2010. PMID: 20577000
Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.
Sánchez-Tapias JM, Forns X, Ampurdanés S, Titó L, Planas R, Viver JM, Acero D, Torres M, Mas P, Morillas R, Forné M, Espinós J, Llovet JM, Costa J, Olmedo E, López-Labrador FX, Jiménez de Anta MT, Rodés J. Sánchez-Tapias JM, et al. Among authors: torres m. Gut. 1996 Apr;38(4):603-9. doi: 10.1136/gut.38.4.603. Gut. 1996. PMID: 8707096 Free PMC article. Clinical Trial.
Mixed cryoglobulinemia and hepatitis C virus infection.
Sobrino J, Torres M, Rodriguez E, Titó L, Ercilla G, Celis R. Sobrino J, et al. Among authors: torres m. Am J Gastroenterol. 1992 Sep;87(9):1227-8. Am J Gastroenterol. 1992. PMID: 1519595 No abstract available.
[Genotype and phenotypic expression of hereditary hemochromatosis in Spain].
Pardo A, Quintero E, Barrios Y, Bruguera M, Rodrigo L, Vila C, Acero D, Guarner C, Pascual S, López L, Moreno R, Fábrega E, Andrade R, Peláez G, Santos J, Buti M, Torres M; Grupo de Hemocromatosis Hereditaria de la AEEH. Pardo A, et al. Among authors: torres m. Gastroenterol Hepatol. 2004 Oct;27(8):437-43. doi: 10.1016/s0210-5705(03)70500-7. Gastroenterol Hepatol. 2004. PMID: 15388046 Spanish.
Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study.
Jara-Palomares L, Bikdeli B, Jiménez D, Muriel A, Demelo-Rodríguez P, Moustafa F, Villalobos A, López-Miguel P, López-Jiménez L, Otálora S, Peris ML, Amado C, Chopard R, Rivera-Cívico F, Monreal M; RIETE Investigators. Jara-Palomares L, et al. EClinicalMedicine. 2024 May 25;73:102659. doi: 10.1016/j.eclinm.2024.102659. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38828131 Free PMC article.
3,856 results